Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9775904
SERIAL NO

14679743

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to dual GLP-1/glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI54 RUE LA BOETIE PARIS 75008

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bossart, Martin Frankfurt am Main, DE 24 204
Elvert, Ralf Frankfurt am Main, DE 6 65
Evers, Andreas Frankfurt am Main, DE 46 435
Haack, Torsten Frankfurt am Main, DE 42 455
Stengelin, Siegfried Frankfurt am Main, DE 84 1572
Wagner, Michael Frankfurt am Main, DE 194 2499

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 3, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00